【Generic name of the drug】
1. This product is suitable for the treatment of benign prostatic hyperplasia (BPH) and the prevention of urinary system events: ---- reduces the risk of acute urinary retention; ---- Reduce the risk of requiring transurethral resection of the prostate (TURP) and prostatectomy; 2. This product can shrink the enlarged prostate, improve the urine flow and improve the symptoms related to prostatic hyperplasia. This product is suitable for the treatment of patients with prostate hypertrophy
【Usage and dosage】
The recommended dose is one tablet per day of 5 milligrams, with or without food. Dose for patients with renal insufficiency: Dose adjustment is not required for patients with varying degrees of renal insufficiency (creatinine clearance as low as 9 mL/min) because pharmacokinetic studies have demonstrated no change in the in vivo process of finasteride tablets. Elderly Dose: Although pharmacokinetic studies have shown reduced finasteride clearance in patients over 70 years of age, no adjustment of dosing dose is required.
Shaded, sealed, stored below 30℃